Open AccessRepositioning microbial biotechnology against COVID‐19: the case of microbial production of flavonoids
Author(s) -
Goris Tobias,
PérezValero Álvaro,
Martínez Igor,
Yi Dong,
FernándezCalleja Luis,
San León David,
Bornscheuer Uwe T.,
MagadánCorpas Patricia,
Lombó Felipe,
Nogales Juan
Publication year - 2021
Publication title -
microbial biotechnology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.287
H-Index - 74
ISSN - 1751-7915
DOI - 10.1111/1751-7915.13675
Subject(s) - covid-19 , synthetic biology , biology , coronavirus , computational biology , microbiology and biotechnology , infectious disease (medical specialty) , disease , medicine , pathology
Coronavirus‐related disease 2019 (COVID‐19) became a pandemic in February 2020 and worldwide researchers try to tackle the disease with approved drugs of all kinds, or to develop novel compounds inhibiting viral spreading. Flavonoids, already investigated as antivirals in general, also might bear activities specific for the viral agent causing COVID‐19, SARS‐CoV‐2. Microbial biotechnology and especially synthetic biology may help to produce novel flavonoids with antiviral activity.